Patients who were with HER2-positive and triple-negative BrCa tended to express higher FMNL1 and FMNL2 mRNA levels (Figures 3(a), 3(b), 3(d), and 3(e)) while expressed lower FMNL3 mRNA (Figures 3(c) and 3(f)). Here, FMNL2 is linked to invasive breast carcinoma.